Saturday, December 27, 2025 | 08:45 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 14 - The Smart Investor News

Vodafone Idea shares plunge 12% amid fresh uncertainties in AGR relief

The Supreme Court's order to the government to reconsider the adjusted gross revenue demands is limited only to Vodafone Idea's additional dues

Vodafone Idea shares plunge 12% amid fresh uncertainties in AGR relief
Updated On : 30 Oct 2025 | 10:57 AM IST

BHEL shares up 3% amid heavy volume on strong Q2 show; time to buy or hold?

BHEL has rallied 10% in the last four trading sessions. Analysts at ICICI Securities believe that the company needs to ramp up execution to charter robust growth over the medium term.

BHEL shares up 3% amid heavy volume on strong Q2 show; time to buy or hold?
Updated On : 30 Oct 2025 | 10:45 AM IST

PB Fintech share zooms 5% on robust Q2 insurance growth; buy, sell or hold?

PB Fintech shares rose after the company reported a strong September quarter (Q2FY26) performance, driven by robust growth in its insurance segment.

PB Fintech share zooms 5% on robust Q2 insurance growth; buy, sell or hold?
Updated On : 30 Oct 2025 | 10:08 AM IST

L&T's growth story intact, say analysts after Q2 show; buy, sell, or hold?

Nuvama Institutional Equities and Motilal Oswal Financial Services (MOFSL) have retained their Buy ratings on L&T, signaling confidence in the company's medium-term growth prospects.

L&T's growth story intact, say analysts after Q2 show; buy, sell, or hold?
Updated On : 30 Oct 2025 | 9:58 AM IST

Dr Reddy's plunges 6%, hits 5-month low; why pharma stock under pressure?

Dr Reddy's Laboratories has received a Notice of Non-Compliance from Pharmaceutical Drugs Directorate, Canada, regarding its Abbreviated New Drug Submission for Semaglutide Injection.

Dr Reddy's plunges 6%, hits 5-month low; why pharma stock under pressure?
Updated On : 30 Oct 2025 | 9:48 AM IST

APL Apollo fires on all cylinders; what's next for the stock? Find out here

Analysts at Nuvama noted that APL Apollo launched its new 'SG Premium' product line at around ₹49,500 per tonne to counter competition from secondary steel players.

APL Apollo fires on all cylinders; what's next for the stock? Find out here
Updated On : 30 Oct 2025 | 8:12 AM IST

CreditAccess Grameen shares drop 7% after Q2 results; time to buy the dip?

CreditAccess Grameen share price fell up to 7 per cent today after Q2 results showed slower growth recovery. Analysts, however, remain positive on long-term AUM and profitability outlook

CreditAccess Grameen shares drop 7% after Q2 results; time to buy the dip?
Updated On : 29 Oct 2025 | 2:10 PM IST

SAIL soars 8% on heavy volumes, hits 52-week high. Should you buy or hold?

Till 10:38 AM; a combined 90.32 million equity shares representing 2.2 per cent of total equity of SAIL changed hands on the NSE and BSE.

SAIL soars 8% on heavy volumes, hits 52-week high. Should you buy or hold?
Updated On : 29 Oct 2025 | 10:56 AM IST

Robust Q2, GST tailwind lift M&M Fin to 52-wk high; analysts raise targets

While earnings came in ahead of expectations for M&M Financial Services, analysts remain watchful of persistently high credit costs and moderation in asset growth.

Robust Q2, GST tailwind lift M&M Fin to 52-wk high; analysts raise targets
Updated On : 29 Oct 2025 | 10:53 AM IST

Nuvama, HDFC AMC tank upto 9% today; why are capital market stocks falling?

Sebi has released a consultation paper on overhauling the mutual fund regulations to simplify the rules and reduce costs for investors

Nuvama, HDFC AMC tank upto 9% today; why are capital market stocks falling?
Updated On : 29 Oct 2025 | 10:31 AM IST

JM Financial initiates coverage on Endurance Tech with a 'Buy'; here's why

At the current market price, the brokerage sees around 17 per cent upside for the stock and has set a price target of ₹3,435, based on a 32x FY28E P/E.

JM Financial initiates coverage on Endurance Tech with a 'Buy'; here's why
Updated On : 29 Oct 2025 | 10:03 AM IST

Analysts split on Shree Cement post Q2 show: should you buy, sell, or hold?

While Nuvama Institutional Equities has reiterated its 'Hold' rating on Shree Cement, Choice Institutional Equities has maintained a 'Sell' call, citing expensive valuations and limited upside

Analysts split on Shree Cement post Q2 show: should you buy, sell, or hold?
Updated On : 29 Oct 2025 | 8:36 AM IST

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets

Brokerages maintained a positive stance on SRF, highlighting continued margin strength, steady volume growth, and the company's strategic capex expansion.

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets
Updated On : 29 Oct 2025 | 8:19 AM IST

Chennai Petroleum posts strong Q2; analysts upbeat on GRM, earnings outlook

Chennai Petroleum posted PAT of ₹732 crore in Q2FY26 against a loss of ₹629 crore in Q2FY25, on account of higher GRM at USD 9.1/bbl

Chennai Petroleum posts strong Q2; analysts upbeat on GRM, earnings outlook
Updated On : 28 Oct 2025 | 1:33 PM IST

Syrma, Kaynes surge up to 7%; what's driving EMS stocks on Tuesday?

The Indian government has approved the first batch of seven projects totaling over ₹5,500 crore under ECMS i.e. electronics components manufacturing scheme.

Syrma, Kaynes surge up to 7%; what's driving EMS stocks on Tuesday?
Updated On : 28 Oct 2025 | 12:14 PM IST

Target @₹7,000: IndiGo set to fly higher as Anand Rathi initiates with Buy

Anand Rathi believes IndiGo's disciplined low-cost structure, commanding market share, and strategic global expansion make it a long-term compounding story in Indian aviation.

Target @₹7,000: IndiGo set to fly higher as Anand Rathi initiates with Buy
Updated On : 28 Oct 2025 | 11:30 AM IST

Hindalco, SBI Life rally up to 44% so far in 2025; market cap near ₹2 trn

Thus far in the calendar year 2025, Hindalco (up 44%) and SBI Life (up 37%) have outperformed the BSE Sensex, which rallied 7.7%.

Hindalco, SBI Life rally up to 44% so far in 2025; market cap near ₹2 trn
Updated On : 28 Oct 2025 | 11:04 AM IST

Bata India shares tumble 6% as Q2 earnings miss street's estimates

Bata India shares fell 6 per cent after its second-quarter of the current financial year earnings missed the street's expectations

Bata India shares tumble 6% as Q2 earnings miss street's estimates
Updated On : 28 Oct 2025 | 11:00 AM IST

Indian Oil Corporation reports healthy Q2 results; should you buy or sell?

In Q2, IOCL's consolidated net profit stood at ₹7,817.55 crore, as compared to a net loss of ₹169.58 crore a year ago

Indian Oil Corporation reports healthy Q2 results; should you buy or sell?
Updated On : 28 Oct 2025 | 10:33 AM IST

Nifty PSU Bank index hits new high, rallies 20% in 2 months; here's why

State-run banks, SBI, Uco bank, PSB among others gained up to 2% amid reports that India may considering allowing up to 49% FDI in PSU banks, more than double the current 20% cap.

Nifty PSU Bank index hits new high, rallies 20% in 2 months; here's why
Updated On : 28 Oct 2025 | 10:28 AM IST